Clearmind Medicine, Inc. (CMND)
0.715
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
0.71
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine EPS Diluted (Quarterly) : -0.5734 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.5734 |
| April 30, 2026 | -6.781 |
| January 31, 2026 | -33.17 |
| October 31, 2025 | -47.62 |
| July 31, 2025 | -98.36 |
| April 30, 2025 | -0.1557 |
| January 31, 2025 | -95.50 |
| October 31, 2024 | -82.97 |
| July 31, 2024 | -0.5882 |
| April 30, 2024 | -0.2792 |
| January 31, 2024 | -0.9014 |
| October 31, 2023 | -11.44 |
| July 31, 2023 | -2.434 |
| April 30, 2023 | -16.62 |
| January 31, 2023 | -9910.20 |
| October 31, 2022 | -36.24 |
| July 31, 2022 | -35.76 |
| April 30, 2022 | -57.42 |
| January 31, 2022 | -39.56 |
| October 31, 2021 | -48.25 |
| Date | Value |
|---|---|
| July 31, 2021 | -24.75 |
| April 30, 2021 | -7.000 |
| January 31, 2021 | -3.587 |
| October 31, 2020 | -2.661 |
| July 31, 2020 | -3.648 |
| April 30, 2020 | -2.606 |
| January 31, 2020 | -1.531 |
| October 31, 2019 | -1.530 |
| July 31, 2019 | -1.321 |
| April 30, 2019 | -2.216 |
| January 31, 2019 | -1.352 |
| October 31, 2018 | -8.767 |
| July 31, 2018 | -1.201 |
| April 30, 2018 | -0.3175 |
| January 31, 2018 | -1.906 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.434 |
| NervGen Pharma Corp. | -0.2283 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
| Lexaria Bioscience Corp. | -1.204 |
| Target Group, Inc. (Canada) | -0.0004 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9073M |
| Total Expenses (Quarterly) | 0.9073M |
| Enterprise Value | -12.60M |
| Earnings Yield | -12.33K% |
| Normalized Earnings Yield | -17013.13 |